These allow many people to take their HIV treatment in one tablet, once a day. These one-pill-a-day HIV treatments are often known as ‘single-tablet regimens’ or STRs. In the UK, these single-tablet ...

Improving the quality of life of patients living with HIV, as well as reducing long-term toxicity and promoting patient adherence, are the objectives of a new antiretroviral therapy in a single ...

Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options.

PrEP is currently offered on the NHS as a daily tablet which, if taken correctly, significantly reduces the risk of HIV in people likely to be exposed to the virus. Dr Steve Taylor, a principal ...